Estimates of wildlife trade for traditional Asian medicine should include that of the caterpillar fungus Ophiocordyceps sinensis (Nature 480, S101–S103; 2011).
The fungus, used to treat asthma and other diseases, is legally harvested on a huge scale in Tibet and the Himalayas, and is one of the world's most expensive natural medical resources. Some 85–185 tonnes are collected annually by the local population for a global market worth between US$5 billion and $11 billion.
Large increases in the price (up by 900% from 1997 to 2008) and trade of caterpillar fungus have encouraged more intensive harvesting. My informal survey of harvesters in the Himalayas reveals that caterpillar fungus abundance is dwindling: the average harvest per collector dropped by around half between 2006 and 2010. Harvesters are extending their range as a result, risking overexploitation of a pristine landscape and more ecosystem degradation.
Conservation efforts must be initiated to halt the decline of this species, which is causing a loss of biodiversity and threatening local livelihoods.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shrestha, U. Asian medicine: A fungus in decline. Nature 482, 35 (2012). https://doi.org/10.1038/482035b
Published:
Issue Date:
DOI: https://doi.org/10.1038/482035b
This article is cited by
-
Harvesters’ perceptions of population status and conservation of Chinese caterpillar fungus in the Dolpa region of Nepal
Regional Environmental Change (2015)
-
An assessment of Yarsagumba (Ophiocordyceps sinensis) collection in Dhorpatan Hunting Reserve, Nepal
Journal of Mountain Science (2014)